Pharmaceutical impurity reference standards are crucial for ensuring the safety and efficacy of medications. Innovations in this field are driving advancements in life sciences research, offering new ...

SINGAPORE, March 20, 2026 /PRNewswire/ -- MGI Tech Singapore Pte. Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and the Department ...

Historic UK–US Pharmaceutical Partnership Signals Step Change for Health Regulation, Innovation and Investment ...

Opinions expressed by Digital Journal contributors are their own. In the ever-evolving landscape of pharmaceuticals, innovation is not just desirable; it’s essential. By their very nature, medicine ...

Pharmaceutical innovation in South Africa is reaching new heights, thanks to the transformative partnership between the Austell Al Noor Foundation and Wits University. Collaborations like this empower ...

ST. LOUIS--(BUSINESS WIRE)--The API Innovation Center (APIIC) today announced that it has been awarded funding by the Administration for Strategic Preparedness and Response’s (ASPR) Center for ...

Recent health news highlights innovations and challenges in pharmaceuticals: Incyte reports success in skin disease treatment trials, Insilico Medicine secures a lucrative partnership with Eli Lilly ...

In the opening remarks, Michael Kopcha, Director of the Office of Pharmaceutical Quality (OPQ), offered CDER’s perspective on advanced manufacturing and pharmaceutical quality. He began the ...

India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based g ...

A summary of recent advancements and obstacles in health and pharmaceutical sectors includes Germany's proposals to cap statutory health insurance costs, Insilico Medicine's AI partnership with Eli ...

November 30, 2022 - The U.S. Supreme Court has granted certiorari in Amgen v. Sanofi, (Appeal No. 2021-0757 (Fed. Cir. 2022)), a case that challenges the current interpretation of the requirements ...